公开(公告)号：US12226459B2

公开(公告)日：2025-02-18

申请号：US18695013

申请日：2023-08-30

Applicant: ROUSSELOT B.V.

Inventor： Barbara De Klerk-Engels ,  Elien Monique Gevaert ,  Praneeth Reddy Kuninty ,  Janne Prawitt ,  Nicolina Virgilio

IPC: A61K38/39 ,  A61K9/14 ,  A61K38/01 ,  A61P43/00 ,  C07K14/78

Abstract: The present invention relates to a use of collagen hydrolysate after intensive care unit (ICU) stay. The collagen hydrolysate improves the recovery and prevents and/or treats post intensive care syndrome (PICS) after ICU stay. The collagen hydrolysate is preferably administered as a supplement in the context of ICU stay and/or PICS. Collagen hydrolysate is generally-accepted to be safe and therefore can be taken as a preventive and long-term measure.